Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-09

Clinical Trial Update: ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety and pharmacodynamic effects of ALKS 33-BUP when given alone and when co-administered with cocaine in individuals with cocai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALKS 33-BUP (ALKS 33-BUP)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Cocaine Abuse | Phase 1 | Status: COMPLETED